FORBES-TATE

Lobbying for VIR BIOTECHNOLOGY, INC. · Clinical Stage immunology company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $50,000.00 income · posted Apr 19, 2026

Lobbying activity 1

Health Issues

Issues related to biopharmaceutical research, development, and manufacturing for infectious disease products.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.